Rapid IO Signature Development
IO 360™ Panel
Faster than qPCR. Simpler than NGS.
Expertly Curated. Ready to Use.
New Cell Press Supplement
Pathological Mechanisms of Neurodegeneration
Small Sample. Big Insight.
nCounter® Analysis System
More insights from
Prosigna® Breast Cancer Prognostic Gene Signature Assay
Empowering personalized treatment decisions
Learn More *See product pages for regulatory status information
on actionable answers
Sergio Rutella, M.D., Ph.D., FRCPath is a Professor of Cancer Immunotherapy at the John van Geest Cancer Research Centre at Nottingham Trent University. His research focuses on acute myeloid leukemia (AML), an aggressive form of cancer that originates in the bone marrow. We recently spoke with Dr. Rutella about his research and the challenges of studying this disease.
Robin Lynn White
December 14, 2017
nCounter® Analysis in Complex Biology:
Gene expression profile predicts response to pembrolizumab
A video review of JCI publication by Ayers, et al:
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
Digital Detection of Sarcoma Fusion Genes - JAN 17, 2018 9:00 AM PST
Tony Ng MD, PhD, FRCPC, Consultant Pathologist BCCA and Vancouver General Hospital
Fusion oncogenes can occur throughout the genome and conjugate with novel partners, necessitating a technology that can robustly identify both known and unknown fusion types. Currently, most laboratories remain dependent on uni-plexed assays such as FISH, while next-generation sequencing approaches remain relatively cost-prohibitive. Join Tony Ng in this webinar as he discusses his experience in detecting the vast majority of sarcoma fusion gene variants with short turnaround time and low FFPE tissue requirements.
Matt Goddeeris, Principal Scientist, Mitobridge
Mitobridge has used NanoString PlexSet Reagents for gene expression, systematically interrogating disease-related changes in mitochondrial activity and translating unique insights into potential new treatments.
Deciphering the complexities of Neurodegeneration and Neuroinflammation with gene expression profiling - FEB 13, 2018 9:30 AM PST
Kelly Miller, Field Applications Scientist, NanoString Technologies
In this webinar, we demonstrate the robust performance of the nCounter® Analysis platform for gene expression profiling of human post-mortem brain specimens, human blood samples and tissue from mouse models of neurodegenerative disease with an emphasis on performance and reproducibility in FFPE samples. We will discuss data generated using post-mortem Alzheimer’s and Parkinson’s disease brain tissue that was profiled with our new Neuropathology gene expression panel...